Growth hormone secretion and sensitivity in children born small for gestational age

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 85, Issue 417, 1996, Pages 15-16

  Chatelain, P G ^a   Cauderay, M C ^a   De Zegher, F ^b   Claris, O ^c   Salle, B ^c   Tauber, M ^d   Chaussain, J L ^e  

^a HÔPITAL DEBROUSSE   (France)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITÉ LYON 1   (France)

^d UNIVERSITÉ DE TOULOUSE   (France)

^e HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

CATCH UP GROWTH; CLINICAL TRIAL; CONFERENCE PAPER; FEMALE; FETUS; GESTATIONAL AGE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE SENSITIVITY; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; POSTNATAL GROWTH; PRIORITY JOURNAL; SHORT STATURE; SUBCUTANEOUS DRUG ADMINISTRATION; TURNER SYNDROME;

EID: 0030484989     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Usher R, MacLean F. Intrauterine growth of live born caucasian infants at sea level. J Pediatr 1969;74:901-10
2. Niklasson A, Ericson A, Fryer J, Karlberg J, Lawrence C, Karlberg P. An update of the Swedish Reference Standards for weight, length and head circumference at birth for given gestational age (1977-1981; n = 476,588) Acta Paediatr Scand 1991;80:756-62
3. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity and weight velocity in British children. Arch Dis Child 1966;41:454-71
4. Gluckman P, Harding J. The regulation of fetal growth. In: Hernandez M, Argent J, editors. Human growth: basic and clinical aspects. Amsterdam: Excerpta Medica, 1992:253-9
5. Barker DJP. Fetal growth and adult disease. Br J Obstet Gynaecol 1992;99:275-82
6. McKusick VA. Silver-Russell dwarfism. In: McKusick VA, editor. Mendelian inheritance in man. Baltimore: The Johns Hopkins University Press, 1992:1696-7
7. Kitchen WH, Doyle LW, Ford GW, Callanan C. Very low birth-weight and growth to age 8 years. I: Weight and height. Am J Dis Child 1992;146:40-5
8. Fitzhardinge PM, Steven EM. The small for date infant. I. Later growth patterns. Pediatrics 1972;49:671-4
9. Ross G, Lipper EG, Auld PAM. Growth achievement of very low birth weight premature children at school age. J Pediatr 1990;117:307-9
10. Hack M, Merkatz IR, McGrath SK, Jones PK, Fanaroff AA. Catch-up growth in very low birth-weight infants: clinical correlates. Am J Dis Child 1984;138:370-5
11. Deiber M, Chatelain P, Naville D, Putet G, Salle B. Functional hypersomatotropism in small for gestational age (SGA) newborn infants. J Clin Endocrinol Metab 1990;68:232-4
12. Albertsson-Wickland K. Growth hormone secretion and growth hormone treatment in children with intra-uterine growth retardation. Acta Paediatr Scand Suppl 1989;349:35-41
13. Tanner JM, Whitehouse RH, Hugues PCR, Vince FP. Effect of human growth hormone for one to seven years on growth of 100 children with growth hormone deficiency, low birth weight, inherited smallness, Turner's syndrome and other complaints. Arch Dis Child 1971;4:745-82
14. Grunt JA, Enriques AR, Daughaday WH, Budd S. Acute and long term responses to hGH in children with idiopathic small-for-date dwarfism. J Clin Endocrinol Metab 1972;35:157-68
15. Foley TP Jr, Thompson RG, Shaw M, Baghdassavian A. Growth responses to human growth hormone therapy in patients with intra-uterine growth retardation. J Pediatr 1974;84:635-41
16. Lanes R, Plotnick LP, Lee PA. Sustained effect of human growth hormone in patients with intra-uterine growth retardation. Pediatrics 1979;63:731-5
17. de Zegher F, Albertsson-Wikland K, Wilton P, Chatelain P, Jonsson B, Löfström A, et al. Growth hormone treatment of short children born small for gestational age: metanalysis of four independent, randomized, controlled, multicentre studies. Acta Paediatr Suppl 1996;417:27-31
18. Chatelain P, Job JC, Blanchard J, Ducret JP, Olivier M, Sagnard L, et al. Dose-dependent catch-up growth after 2 years of growth hormone treatment in intrauterine growth-retarded children. J Clin Endocrinol Metab 1994;78:1454-60
19. Stanhope R, Preece MA, Hamhill G. Does growth hormone treatment improve final height attainment of children with intra-uterine growth retardation? Arch Dis Child 1991;66:1180-3
20. Chatelain PG, on behalf of the International Board of the Kabi Pharmacia International Growth Study. Auxology and response to growth hormone treatment of patients with intrauterine growth retardation or Silver-Russell syndrome: analysis of data from the Kabi Pharmacia International Growth Study. Acta Paediatr Suppl 1993;391:79-81
21. Cauderay M, Olivier M, Wang XM, Carita P, Bertrand AM, Chatelain P. Further evidence for difference in sensitivity to growth hormone treatment in GH deficient and GH sufficient short children. ESPE 1996 (Abstract).
22. Laron Z, Blum W, Chatelein P, Ranke M, Rosenfeld R, Savage M, et al. Classification of GH insensitivity syndrome. J Pediatr 1993;122:241